Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry

Fig. 3

Kaplan–Meier analysis for survival in treatment. Kaplan–Meier analysis for mortality in the SIPFR cohort according to a, b patients with and without anti-fibrotic treatment in patients in all and GAP stage over 1; c, d patients with anti-fibrotic treatment (nintedanib, pirfenidone, switched treatment) and untreated in patients in all and GAP stage over 1

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us